# L-Carvone (Monoterpene)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/l-carvone
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** (S)-(-)-Carvone, L-(-)-Carvone, Spearmint ketone, Caraway ketone, p-Mentha-6,8-dien-2-one, Carvol, 2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one

## Overview

L-carvone is a monoterpene found in spearmint and caraway that modulates [inflammatory pathway](/ingredients/condition/inflammation)s through COX and lipoxygenase inhibition. This bioactive compound demonstrates preliminary anti-inflammatory, analgesic, and anti-cancer properties in preclinical studies.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) kidney protection: Reduced kidney injury markers and inflammation in preclinical models (PMID: 41175326) - preliminary evidence only
• Pain relief: Increased pain threshold in sheep models over 6 hours (PMID: 37500407) - preliminary evidence only
• Anti-cancer properties: Inhibited breast cancer cell proliferation via apoptosis in vitro (PMID: 24611509) - preliminary evidence only
• Antioxidant effects: Reduced [oxidative stress](/ingredients/condition/antioxidant) markers in kidney tissue - preliminary evidence only
• [Immunomodulatory](/ingredients/condition/immune-support) activity: Modulates immune pathways via TLR4/NF-κB signaling - preliminary evidence only

## Mechanism of Action

L-carvone exerts [anti-inflammatory](/ingredients/condition/inflammation) effects by inhibiting cyclooxygenase (COX) and lipoxygenase enzymes, reducing pro-inflammatory mediators like prostaglandins and leukotrienes. The compound modulates nuclear factor-kappa B (NF-κB) signaling pathways, decreasing inflammatory cytokine production. Its analgesic properties appear to involve interactions with peripheral nociceptors and central pain processing mechanisms.

## Clinical Summary

Current evidence for L-carvone comes primarily from preclinical animal studies with limited human data. In sheep models, L-carvone demonstrated analgesic effects lasting 6 hours with measurable increases in pain threshold. Kidney protection studies in rodent models showed reduced [inflammatory](/ingredients/condition/inflammation) markers and injury scores, though these findings require human validation. No large-scale clinical trials have been conducted to establish therapeutic efficacy or optimal dosing protocols.

## Nutritional Profile

L-Carvone (IUPAC: (R)-(-)-5-Isopropenyl-2-methylcyclohex-2-enone; C₁₀H₁₄O; MW: 150.22 g/mol) is a monoterpenoid ketone, not a nutritional food source per se, so classical macronutrient/micronutrient profiling does not apply. It is a bioactive volatile compound found naturally in several essential oils. Key details: • Primary natural sources and approximate concentrations: Spearmint (Mentha spicata) essential oil contains 50–80% L-carvone as the dominant constituent; caraway (Carum carvi) seed oil contains 50–65% of the D-enantiomer (the L-form is spearmint-associated); dill (Anethum graveolens) seed oil contains ~30–40% carvone (mixed enantiomers). • Typical dietary exposure: Estimated at low microgram-to-low-milligram levels per day through consumption of spearmint tea, chewing gum, confections, and flavored foods. FEMA GRAS status (flavor use). • Physicochemical properties affecting bioavailability: Lipophilic (LogP ~2.4), volatile liquid (bp ~230°C), readily absorbed across mucosal membranes and GI tract. Oral bioavailability is moderate-to-high in preclinical models but subject to significant first-pass hepatic [metabolism](/ingredients/condition/weight-management) (cytochrome P450-mediated oxidation and reduction yielding dihydrocarvone, carveol, and dihydrocarveol conjugates). • No vitamins, minerals, fiber, or protein content — it is a pure single chemical entity. • Bioactive compound class: Oxygenated monoterpene (monocyclic terpenoid ketone with an α,β-unsaturated carbonyl). The α,β-unsaturated carbonyl moiety is considered the pharmacophoric element responsible for electrophilic reactivity with biological nucleophiles (e.g., [NF-κB](/ingredients/condition/inflammation) pathway modulation, phase II enzyme induction via Nrf2-Keap1 interaction). • Caloric contribution: Negligible at flavoring-level doses. • Safety note: Generally Recognized As Safe (GRAS) by FDA for flavoring use (21 CFR 182.60). ADI not formally established by JECFA but considered safe at typical dietary exposure levels (estimated dietary intake <0.1 mg/kg body weight/day from food flavoring). Higher pharmacological doses used in preclinical studies (50–200 mg/kg in rodent models) far exceed normal dietary intake and should not be extrapolated to human supplementation without clinical trial data.

## Dosage & Preparation

Preclinical oral doses: 25-100 mg/kg daily showed kidney protective effects in mice. Intramuscular: 0.15 mL/kg of 50% solution provided pain relief in sheep. No human dosage data available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

L-carvone appears generally safe when consumed in food amounts, but safety data for supplemental doses is limited. Potential interactions with anticoagulant medications may occur due to its effects on [inflammatory pathway](/ingredients/condition/inflammation)s. Pregnant and nursing women should avoid supplemental L-carvone due to insufficient safety data. Individuals with kidney conditions should consult healthcare providers before use given its experimental kidney-protective properties.

## Scientific Research

No human clinical trials have been conducted on L-carvone. Evidence is limited to preclinical studies including a mouse model of kidney injury (n=36, PMID: 41175326) showing dose-dependent protective effects at 25-100 mg/kg, and a sheep pain study (PMID: 37500407) demonstrating analgesic properties.

## Historical & Cultural Context

No historical or traditional medicine uses are documented in the available research sources. L-carvone's therapeutic applications appear to be based solely on modern scientific investigation.

## Synergistic Combinations

Spearmint extract, Caraway seed, N-acetylcysteine, Quercetin, Alpha-lipoic acid

## Frequently Asked Questions

### What is the difference between L-carvone and D-carvone?

L-carvone and D-carvone are stereoisomers with different aromatic properties - L-carvone provides spearmint's characteristic scent while D-carvone gives caraway its aroma. They may have different biological activities due to their distinct molecular orientations affecting receptor binding.

### What foods naturally contain L-carvone?

L-carvone is naturally found in spearmint essential oil (50-70% concentration), dill seed oil, and caraway oil. Fresh spearmint leaves contain the highest concentrations, with dried spearmint retaining significant L-carvone content.

### How much L-carvone is safe to consume daily?

No established daily intake limit exists for L-carvone supplements. The FDA recognizes L-carvone as Generally Recognized as Safe (GRAS) for food flavoring, but therapeutic dosing requires clinical research to establish safety parameters.

### Can L-carvone help with arthritis pain?

Preliminary animal studies suggest L-carvone may reduce inflammatory pain through COX enzyme inhibition. However, no human clinical trials have specifically tested L-carvone for arthritis, making therapeutic claims premature without proper research validation.

### Does L-carvone interact with blood pressure medications?

No documented interactions exist between L-carvone and blood pressure medications, but its anti-inflammatory effects could theoretically influence cardiovascular function. Patients taking antihypertensive drugs should consult physicians before using L-carvone supplements as a precaution.

### What does clinical research show about L-carvone's anti-inflammatory effects on kidney health?

Current evidence for L-carvone's kidney protective effects comes from preclinical laboratory and animal studies, which have shown reduced kidney injury markers and inflammation in experimental models. However, these findings have not yet been confirmed in human clinical trials, so L-carvone cannot currently be recommended as a kidney health treatment. More research is needed to determine whether these promising preliminary results translate to real-world benefits in people.

### Who should avoid L-carvone supplementation or use it with caution?

Pregnant and nursing women should consult healthcare providers before using L-carvone, as safety data in these populations is limited. Individuals with known monoterpene sensitivities or those taking medications that affect pain perception or kidney function should also seek medical guidance before supplementation. People with hormone-sensitive cancers should exercise caution, as in vitro research has shown L-carvone may affect cancer cell behavior, though this has not been studied in humans.

### What is the difference between L-carvone's pain-relieving mechanism in research versus other pain relief compounds?

L-carvone demonstrated increased pain thresholds in animal models over approximately 6 hours in preliminary studies, suggesting a direct neurological pain-modulating mechanism. Unlike some pain relievers that work through inflammation reduction, L-carvone appears to act on pain perception pathways themselves, though the exact human mechanism remains unclear. Current evidence is limited to animal studies, and human efficacy and duration of action are not yet established.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*